StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.27−0.02 (-0.47%)

Close on Nov 18, 2026Market cap $1.53BP/E –Yield –

Precigen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Precigen's market cap was $1.69B on Nov 11, 2026, against $1.36B a year earlier. Over the last 5 years it ranged from $199.14M to $3.06B, with a median of $395.37M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.69B+14.3%
2025Dec 31, 2025$1.48B+350.9%
2024Dec 31, 2024$328.01M-4.5%
2023Dec 29, 2023$343.57M+8.6%
2022Dec 30, 2022$316.39M-58.7%
2021Dec 31, 2021$767.00M-57.9%
2020Dec 31, 2020$1.82B+104.7%
2019Dec 31, 2019$890.57M-0.7%
2018Dec 31, 2018$896.93M-35.5%
2017Dec 29, 2017$1.39B-51.6%
2016Dec 30, 2016$2.87B-18.1%
2015Dec 31, 2015$3.51B+26.8%
2014Dec 31, 2014$2.77B+19.9%
2013Dec 31, 2013$2.31B–

More Precigen figures

See a number that looks wrong?